Published in PLoS One on May 25, 2012
Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA Intern Med (2014) 1.86
The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model. PLoS One (2015) 1.46
"My older clients fall through every crack in the system": geriatrics knowledge of legal professionals. J Am Geriatr Soc (2014) 1.42
Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav (2013) 1.39
Gender disparities in HIV treatment outcomes following release from jail: results from a multicenter study. Am J Public Health (2014) 1.15
The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis. Am J Public Health (2015) 1.11
Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite study. AIDS Behav (2013) 1.09
HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis (2013) 1.07
Partner violence and health among HIV-infected jail detainees. Int J Prison Health (2013) 0.88
Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum. Int J Drug Policy (2015) 0.88
Incarceration of people living with HIV/AIDS: implications for treatment-as-prevention. Curr HIV/AIDS Rep (2014) 0.87
The feasibility of implementing the HIV seek, test, and treat strategy in jails. AIDS Patient Care STDS (2014) 0.85
Routine testing for blood-borne viruses in prisons: a systematic review. Eur J Public Health (2015) 0.78
Establishing an HIV Screening Program Led by Staff Nurses in a County Jail. J Public Health Manag Pract (2016) 0.78
Alcohol use disorders and antiretroviral therapy among prisoners in Argentina. Int J Prison Health (2013) 0.76
Emergency department use among HIV-infected released jail detainees. J Urban Health (2015) 0.75
Infectious Diseases and the Criminal Justice System. Am J Med Sci (2016) 0.75
HIV Testing, HIV Positivity, and Linkage and Referral Services in Correctional Facilities in the United States, 2009-2013. Sex Transm Dis (2015) 0.75
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01
The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis (2011) 16.88
Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS (2006) 11.20
Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am J Public Health (1999) 8.91
HIV prevalence estimates--United States, 2006. MMWR Morb Mortal Wkly Rep (2008) 7.76
Universal voluntary testing and treatment for prevention of HIV transmission. JAMA (2009) 7.20
Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis (2004) 6.27
Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis (2008) 5.85
Accessing antiretroviral therapy following release from prison. JAMA (2009) 5.45
HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One (2009) 4.69
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS (2010) 4.05
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet (2010) 3.90
Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 3.86
Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis (2008) 3.38
Projected life expectancy of people with HIV according to timing of diagnosis. AIDS (2012) 3.09
Results of a rapid HIV screening and diagnostic testing program in an urban emergency department. Ann Emerg Med (2008) 3.07
Sexual behaviours of HIV-seropositive men and women following release from prison. Int J STD AIDS (2006) 2.58
Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.43
A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend (2010) 2.38
Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis (2011) 2.12
HIV transmission among male inmates in a state prison system--Georgia, 1992-2005. MMWR Morb Mortal Wkly Rep (2006) 1.77
The economic burden of late entry into medical care for patients with HIV infection. Med Care (2010) 1.69
HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners. Am J Drug Alcohol Abuse (2010) 1.48
Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr (2010) 1.47
The Direct Medical Costs of Late Presentation (<350/mm) of HIV Infection over a 15-Year Period. AIDS Res Treat (2011) 1.41
Adherence to HIV treatment and care among previously homeless jail detainees. AIDS Behav (2013) 1.33
Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care (2011) 1.31
Diversity of release patterns for jail detainees: implications for public health interventions. Am J Public Health (2011) 1.27
HIV-related research in correctional populations: now is the time. Curr HIV/AIDS Rep (2011) 1.25
Recognition of undiagnosed HIV infection: an evaluation of missed opportunities in a predominantly urban minority population. AIDS Patient Care STDS (2005) 1.22
Routine jail-based HIV testing - Rhode Island, 2000-2007. MMWR Morb Mortal Wkly Rep (2010) 1.05
HIV screening of male inmates during prison intake medical evaluation--Washington, 2006-2010. MMWR Morb Mortal Wkly Rep (2011) 1.01
The impact of antiretroviral therapy in a cohort of HIV infected patients going in and out of the San Francisco county jail. PLoS One (2009) 0.94
Comparison of missed opportunities for earlier HIV diagnosis in 3 geographically proximate emergency departments. Ann Emerg Med (2011) 0.90
Effect of expanded HIV testing programs on the status of newly diagnosed HIV-infected patients in two Veterans Health Administration facilities: 1999-2009. J Acquir Immune Defic Syndr (2011) 0.85
Late presentation and transmitted drug resistance mutations in new HIV-1 diagnoses in Detroit. Int J Infect Dis (2011) 0.80
Managing the health effects of climate change: Lancet and University College London Institute for Global Health Commission. Lancet (2009) 12.03
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04
Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis (2004) 6.27
Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol (2008) 4.41
Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med (2003) 4.30
Effect of Ebola progression on transmission and control in Liberia. Ann Intern Med (2014) 3.96
Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet (2003) 3.70
A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend (2010) 2.38
Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis (2011) 2.12
Substance abuse, violence, and HIV in women: a literature review of the syndemic. J Womens Health (Larchmt) (2011) 2.10
Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells. Cancer Res (2010) 1.91
The role of area-level influences on prostate cancer grade and stage at diagnosis. Prev Med (2004) 1.79
Managing HIV/AIDS in correctional settings. Curr HIV/AIDS Rep (2005) 1.76
An instrument to assess the obesogenic environment of child care centers. Am J Health Behav (2007) 1.74
Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice. J Acquir Immune Defic Syndr (2006) 1.73
A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells. Neoplasia (2010) 1.70
Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health (2010) 1.66
Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study. Soc Sci Med (2002) 1.66
Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy (2007) 1.65
Mortality of dialysis patients according to influenza and pneumococcal vaccination status. Am J Kidney Dis (2012) 1.61
Models for integrating buprenorphine therapy into the primary HIV care setting. Clin Infect Dis (2006) 1.55
Ordered mesoporous materials from metal nanoparticle-block copolymer self-assembly. Science (2008) 1.55
Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and research. AIDS (2011) 1.52
Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project. AIDS Behav (2011) 1.49
HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners. Am J Drug Alcohol Abuse (2010) 1.48
Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr (2010) 1.47
HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications. Int J Drug Policy (2007) 1.40
Antiretroviral treatment regimen outcomes among HIV-infected prisoners. HIV Clin Trials (2007) 1.39
Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav (2013) 1.39
Low perceived risk and high HIV prevalence among a predominantly African American population participating in Philadelphia's Rapid HIV testing program. AIDS Patient Care STDS (2011) 1.38
A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Curr HIV/AIDS Rep (2012) 1.37
Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners. PLoS One (2012) 1.37
Understanding the revolving door: individual and structural-level predictors of recidivism among individuals with HIV leaving jail. AIDS Behav (2013) 1.35
Linking HIV-positive jail inmates to treatment, care, and social services after release: results from a qualitative assessment of the COMPASS Program. J Urban Health (2010) 1.35
Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users. J Acquir Immune Defic Syndr (2006) 1.33
Routine opt-out HIV testing strategies in a female jail setting: a prospective controlled trial. PLoS One (2009) 1.33
Adherence to HIV treatment and care among previously homeless jail detainees. AIDS Behav (2013) 1.33
Implementing methadone maintenance treatment in prisons in Malaysia. Bull World Health Organ (2013) 1.33
A prospective controlled trial of routine opt-out HIV testing in a men's jail. PLoS One (2009) 1.32
Strategies for primary HIV prevention that target behavioral change. Clin Infect Dis (2007) 1.31
HIV control efforts should directly address incarceration. Lancet Infect Dis (2007) 1.31
Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care (2011) 1.31
Clinical care of the HIV-infected drug user. Infect Dis Clin North Am (2007) 1.30
Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav (2010) 1.29
Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial. J Acquir Immune Defic Syndr (2009) 1.29
Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol (2009) 1.27
Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations. Clin Infect Dis (2008) 1.26
Strategies used in the detection of acute/early HIV infections. The NIMH Multisite Acute HIV Infection Study: I. AIDS Behav (2009) 1.26
HIV-related research in correctional populations: now is the time. Curr HIV/AIDS Rep (2011) 1.25
Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis (2013) 1.24
The impact of needle exchange-based health services on emergency department use. J Gen Intern Med (2002) 1.22
Adaptation of an evidence-based intervention targeting HIV-infected prisoners transitioning to the community: the process and outcome of formative research for the Positive Living Using Safety (PLUS) intervention. AIDS Patient Care STDS (2009) 1.22
Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis (2013) 1.18
Rapid HIV testing in rapidly released detainees: next steps. Sex Transm Dis (2009) 1.17
Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug Alcohol Depend (2013) 1.15
Gender disparities in HIV treatment outcomes following release from jail: results from a multicenter study. Am J Public Health (2014) 1.15
Challenges in managing HIV in people who use drugs. Curr Opin Infect Dis (2015) 1.13
Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy. AIDS Behav (2007) 1.11
Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDS (2010) 1.11
Emergency department use by released prisoners with HIV: an observational longitudinal study. PLoS One (2012) 1.11
Linkage to HIV care for jail detainees: findings from detention to the first 30 days after release. AIDS Behav (2013) 1.11
Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative. J Acquir Immune Defic Syndr (2011) 1.10
Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr (2011) 1.09
Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite study. AIDS Behav (2013) 1.09
Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention. Drug Alcohol Depend (2011) 1.09
Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics. J Acquir Immune Defic Syndr (2011) 1.09
The association between history of violence and HIV risk: a cross-sectional study of HIV-negative incarcerated women in Connecticut. Womens Health Issues (2007) 1.08
HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis (2013) 1.07
Patterns of homelessness and implications for HIV health after release from jail. AIDS Behav (2013) 1.07
Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users. Subst Abus (2011) 1.06
Influenza vaccination coverage among pregnant women--United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep (2014) 1.06
The diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia. PLoS One (2013) 1.06
At the crossroads: HIV prevention and treatment for people who inject drugs in Ukraine. Addiction (2013) 1.04
Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV. J Int AIDS Soc (2009) 1.04
HIV testing in correctional institutions: evaluating existing strategies, setting new standards. AIDS Public Policy J (2007) 1.03
Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia. Am J Drug Alcohol Abuse (2010) 1.03
Integrating buprenorphine maintenance therapy into federally qualified health centers: real-world substance abuse treatment outcomes. Drug Alcohol Depend (2013) 1.03
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine. J Acquir Immune Defic Syndr (2011) 1.02
Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence. Am J Drug Alcohol Abuse (2007) 1.02
Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market. Am J Drug Alcohol Abuse (2009) 1.02
Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS Behav (2013) 1.02
History of arrest and associated factors among men who have sex with men. J Urban Health (2011) 1.02
STAT3 can be activated through paracrine signaling in breast epithelial cells. BMC Cancer (2008) 1.01
New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells. Cancer Sci (2009) 1.01
Screening for drug and alcohol use disorders and their association with HIV-related sexual risk behaviors among men who have sex with men in Peru. PLoS One (2013) 1.00
New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells. BMC Cancer (2009) 1.00
Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community. PLoS One (2013) 1.00
An assessment of health-care students' attitudes toward patients with or at high risk for HIV: implications for education and cultural competency. AIDS Care (2014) 0.99
Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes. Contemp Clin Trials (2011) 0.99
Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial. J Acquir Immune Defic Syndr (2007) 0.99
Investigation of a putative role for FLVCR, a cytoplasmic heme exporter, in Diamond-Blackfan anemia. Blood Cells Mol Dis (2005) 0.98
Design and validation of a metabolic disorder resequencing microarray (BRUM1). Hum Mutat (2010) 0.98
Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence. J Subst Abuse Treat (2012) 0.98
Randomized, controlled trials of directly administered antiretroviral therapy for HIV-infected patients: questions about study population and analytical approach. Clin Infect Dis (2006) 0.96